Subscribe

Tag: semaglutide

HomeTagsSemaglutide

Become a member

Get the best offers and updates relating to Liberty Case News.

﹢ Subscribe

Experimental Weight Loss Drug Beat Ozempic and Wegovy in Early Trial

trendyvoice -
Ed Cara ...

‘Gelzempic’ Could Make Popular Weight Loss Drugs Easier to Take

trendyvoice -
Ed Cara ...

23andMe Exits Drug Development to Step Into Weight-Loss Wave

trendyvoice -
(Bloomberg) -- 23andMe Holding Co.’s strategy is shifting as the struggling DNA-testing firm shuts down its in-house drug development effort...

Don’t Look Now, But Ozempic Might Help You Quit Smoking, Too

trendyvoice -
Ed Cara ...

Messing With Brain Proteins Made Ozempic-Like Drugs More Effective, Less Nauseating

trendyvoice -
Adam Kovac ...

Study Links Risk of Vision Loss to Weight Loss Drug Semaglutide, Experts Call for Monitoring – News18

trendyvoice -
News18 There could be a potential risk of vision loss associated with the widely prescribed weight loss and anti-diabetic drug Semaglutide, a...

Ozempic and Wegovy Linked to Rare Blindness Risk, Study Finds

trendyvoice -
Ed Cara ...

How to Avoid ‘Fauxzempic,’ According to WHO Experts

trendyvoice -
Ed Cara The World Health Organization is warning the public to stay away from counterfeit Ozempic, or “fauxzempic.” The agency has recently...

Pharma Exec Will Testify About Ozempic’s Absurd Price Tag After Pressure From Bernie Sanders

trendyvoice -
Matt Novak Bernie Sanders, the independent Senator from Vermont, has long been railing against the price of prescription medications in the U.S.,...

The Truth About Ozempic and Muscle Loss

trendyvoice -
Ed Cara It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide....

Novo’s India GGC is the secret sauce behind Ozempic’s success | India News – Times of India

trendyvoice -
Shilpa Phadnis BENGALURU: The secret sauce behind Novo Nordisk's blockbuster drug, Ozempic, is the Danish pharmaceutical company's India team, which played a...

Blockbuster Diabetes and Weight-Loss Drug Semaglutide Can Reduce Kidney Failure, Heart Attack Risk: NEJM Study – News18

trendyvoice -
News18 Semaglutide, the mega-seller diabetes and weight-loss drug, can significantly reduce the risk of side effects such as kidney failure, heart attacks,...

Categories

BusinessCryptoEntertainmentGlobal NewsHealthInvestmentsSportsTechTravel
spot_img

Subscribe for exclusive content

We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.

Subscribe

Categories

Copyright by Neev Advisory.